Generic Firms Use Pediatric Exclusivity As Weapon In Toprol XL Fight
Executive Summary
Sandoz and KV Pharmaceutical are locked in a regulatory struggle to keep each other's generic versions of AstraZeneca's Toprol XL (metoprolol extended release) off the market